This article briefly reviews the literature on the incidence of hypertension in the diabetic population, the risks associated with this combination of conditions, and the nonpharmacologic and other therapies available to lower blood pressure in these patients. Although several studies of nonpharmacologic therapies and diuretics are considered, the emphasis is on the reported advantages and disadvantages of β-blockers, centrally acting agents, α-adrenergic-blocking agents, calcium-channel blockers, and angiotensin-converting enzyme inhibitors.

This content is only available via PDF.